ClinicalTrials.Veeva

Menu

Contingency Management for Smoking Cessation in Pregnant Minority Women

University of Miami logo

University of Miami

Status

Withdrawn

Conditions

Cigarette Smoking

Treatments

Behavioral: Prize-based Contingency Management (CM)
Other: Quit Smoking Now (QSN)

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT02195570
20130654
R34DA031973 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The long-term goal of this research is to reduce tobacco-related disparities in maternal and infant health outcomes by improving smoking cessation and relapse prevention interventions for minority pregnant and postpartum women, who have been significantly underrepresented in smoking cessation research. This study will examine the feasibility and efficacy of a prize-based contingency management approach for increasing smoking cessation and preventing relapse among socioeconomically disadvantaged minority pregnant smokers. First, the intervention will be pretested with 10 pregnant low-income minority smokers and then refined based on acceptability survey and focus group data. Next, a pilot study will be conducted. 60 highly disadvantaged minority women, recruited from the outpatient obstetric clinics at a large teaching hospital, who report daily smoking and who meet other eligibility criteria will be enrolled and randomized to one of two study conditions: 1) Standard Psychoeducational Intervention (6-week, individually-administered, pregnancy-specific Quit Smoking Now curriculum, as currently implemented in the clinic; QSN Only); 2) Standard Psychoeducational Intervention plus Contingency Management (provision of incentives contingent on biochemically-verified abstinence; QSN-CM). Abstinence monitoring via expired carbon monoxide and salivary cotinine levels will occur in both groups beginning on the first quit day and continuing through 3-months postpartum. Only participants in the QSN-CM group will be reinforced for biochemically-verified abstinence with chances to win prizes ranging in value from approximately $1 to $100 ('fishbowl' or 'prize bowl' method). Study outcomes will be assessed through follow-up research exams (delivery and 6-months postpartum) and hospital chart reviews. The primary hypothesis is that that women randomized to the QSN-CM condition will have higher rates of abstinence during pregnancy and postpartum compared to women receiving standard of care alone. Results should advance scientific knowledge regarding effective methods for promoting and maintaining smoking abstinence among pregnant disadvantaged women and provide preliminary feasibility and efficacy data needed to support a larger randomized controlled trial.

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • self-identified daily smoker (at least 1 cigarette/day)
  • <28 weeks gestation
  • 18 years or older
  • resident of Miami-Dade County, Florida
  • able to read and speak in English or Spanish
  • plans to continue prenatal care with Jackson Health System
  • plans to remain in the Miami-Dade County metropolitan area for at least 6 months following delivery.

Exclusion criteria

  • participation in another smoking cessation intervention within the past year
  • use of nicotine replacement therapy (NRT) anytime during pregnancy
  • inability to give informed consent
  • incarceration
  • reported regular use of alcohol (>3 times/week) or marijuana (>weekly); any cocaine or opiates in past year; or a positive toxicology for these drugs.

Study withdrawal will occur in the case of pregnancy termination, fetal demise or by participant request.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

QSN with CM (QSN-CM).
Experimental group
Description:
Women will receive standard of care Quit Smoking Now tobacco education and support plus prize-based contingency management. Their smoking status will be monitored from quit date through 3 months postpartum via carbon monoxide and salivary cotinine levels. Women will earn chances to win prizes each time they test negative for smoking according to biochemical measures.
Treatment:
Behavioral: Prize-based Contingency Management (CM)
Other: Quit Smoking Now (QSN)
QSN Only
Active Comparator group
Description:
Women receive the standard of care Quit Smoking Now tobacco education and support only. Smoking status will be monitored from quit date through 3 months postpartum via carbon monoxide and salivary cotinine levels. Incentives are given for providing breath and salivary samples but are not contingent on smoking status.
Treatment:
Other: Quit Smoking Now (QSN)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems